Aspire Pharma licenses and develops niche generic pharmaceutical products that offer innovative formulations, value for money for payors, and reliable supply arrangements in markets which are often underserved. The business has a highly diversified portfolio of more than 250 products across a number of categories, including branded specialty products and unbranded niche generics in therapeutic areas such as urology, ophthalmology, CNS and dermatology. Aspire has an asset-light business model that outsources manufacturing and distribution, whilst it focuses on R&D, business development and sales and marketing.

Pour de plus amples informations, consultez le site :